Deregulated microRNAs and Adiponectin in Postmenopausal Women with Breast Cancer

被引:14
|
作者
Isabel Pena-Cano, Maria [1 ]
Saucedo, Renata [2 ]
Morales-Avila, Enrique [1 ]
Valencia, Jorge [2 ]
Zavala-Moha, Jose A. [3 ]
Lopez, Adriana [4 ]
机构
[1] Univ Autonoma Estado Mexico, Fac Chem, Toluca, Mexico
[2] Inst Mexicano Seguro Social, Endocrine Res Unit, Natl Med Ctr, Cuauhtemoc 330, Mexico City 06720, DF, Mexico
[3] Reg Hosp 251, Inst Mexicano Seguro Social, Oncol Dept, Mexico City, DF, Mexico
[4] Reg Hosp 251, Inst Mexicano Seguro Social, Pathol Dept, Mexico City, DF, Mexico
关键词
Breast cancer; Menopause; Obesity; MicroRNA; Adiponectin; Leptin; Insulin-like growth factors; MIR-17-92; CLUSTER; OBESITY; OVERWEIGHT; EXPRESSION; LEPTIN; SERUM; METABOLISM; MECHANISMS; MORTALITY; DIAGNOSIS;
D O I
10.1159/000496340
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: Obesity is a risk factor for breast cancer (BC). Some mechanisms through which obesity can lead to cancer development are insulin-like growth factors (IGFs), adipokines, and microRNAs (miRs). The objective of the study was to determine whether miR-17-5p, miR-195-5p, and miR-2213p expressions were deregulated in serum samples of obese and nonobese postmenopausal women with BC. In addition, insulin, adiponectin, leptin and IGFs were analyzed. Methods: Fifty postmenopausal women with newly diagnosed BC and 50 postmenopausal healthy women were evaluated. Differences in miRs between BC and healthy cases and between obese and lean participants were analyzed. Receiver operating characteristic curves for miRs for discriminating patients with or without BC were established, and relationships between the miRs, adipokines, and breast tumor characteristics were also investigated. Results: miR-17-5p and miR-195-5p were higher in patients with BC in comparison to the controls, while miR-221-3p and adiponectin were significantly lower. Increased levels of miR-195-5p allowed the differentiation of BC from controls with a sensitivity of 83.3 and a specificity of 78.3%, and were associated with lobular and poorly differentiated cancer. There was no difference in miRs levels between obese and lean groups. Conclusions: Circulating miRs and adiponectin were deregulated in postmenopausal women with BC. (C) 2019 S. Karger AG, Basel
引用
收藏
页码:369 / 377
页数:9
相关论文
共 50 条
  • [31] Deregulated MicroRNAs involved in P53 Signaling Pathway in Breast Cancer with Focus on Triple-negative Breast Cancer
    Naeimzadeh, Yasaman
    Heidari, Zahra
    Razban, Vahid
    Khajeh, Sahar
    CURRENT MOLECULAR PHARMACOLOGY, 2024, 17
  • [32] Endometrial cancer and endometrial hyperplasia in postmenopausal women with breast cancer
    Montzka, P
    Schultze-Mosgau, A
    Bauer, O
    Diedrich, K
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S39 - S39
  • [33] Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women
    Cust, Anne E.
    Kaaks, Rudolf
    Friedenreich, Christine
    Bonnet, Fabrice
    Laville, Martine
    Lukanova, Annekatrin
    Rinaldi, Sabina
    Dossus, Laure
    Slimani, Nadia
    Lundin, Eva
    Tjonneland, Anne
    Olsen, Anja
    Overvad, Kim
    Clavel-Chapelon, Francoise
    Mesrine, Sylvie
    Joulin, Virginie
    Linseisen, Jakob
    Rohrmann, Sabine
    Pischon, Tobias
    Boeing, Heiner
    Trichopoulos, Dimitrios
    Trichopoulou, Antonia
    Benetou, Vassiliki
    Palli, Domenico
    Berrino, Franco
    Tumino, Rosario
    Sacerdote, Carlotta
    Mattiello, Amalia
    Quiros, J. Ramon
    Mendez, Michelle A.
    Sanchez, Maria-Jose
    Larranaga, Nerea
    Tormo, M. J.
    Ardanaz, Eva
    Bueno-de-Mesquita, H. Bas
    Peeters, Petra H. M.
    van Gils, Carla H.
    Khaw, Kay-Tee
    Bingham, Sheila
    Allen, Naomi
    Key, Tim
    Jenab, Mazda
    Riboli, Elio
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (01): : 255 - 263
  • [34] An update review of deregulated tumor suppressive microRNAs and their contribution in various molecular subtypes of breast cancer
    Dastmalchi, Narges
    Safaralizadeh, Reza
    Baradaran, Behzad
    Hosseinpourfeizi, Mohammadali
    Baghbanzadeh, Amir
    GENE, 2020, 729
  • [35] Adiponectin as a Biomarker of Osteoporosis in Postmenopausal Women: Controversies
    Lubkowska, Anna
    Dobek, Aleksandra
    Mieszkowski, Jan
    Garczynski, Wojciech
    Chlubek, Dariusz
    DISEASE MARKERS, 2014, 2014
  • [36] Adiponectin and bone mineral density in postmenopausal women
    Richards, J. B.
    Valdes, A. M.
    Burling, K.
    Perks, U.
    Spector, T. D.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S23 - S23
  • [37] DIET AND PLASMA ANDROGENS IN POSTMENOPAUSAL VEGETARIAN AND OMNIVOROUS WOMEN AND POSTMENOPAUSAL WOMEN WITH BREAST-CANCER
    ADLERCREUTZ, H
    HAMALAINEN, E
    GORBACH, SL
    GOLDIN, BR
    WOODS, MN
    DWYER, JT
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 1989, 49 (03): : 433 - 442
  • [38] Prognosis of Breast Cancer and Heart Failure in Postmenopausal Women
    Lam, Phillip H.
    Barac, Ana
    Nohria, Anju
    Reding, Kerryn
    Fonarow, Gregg C.
    Pan, Kathy
    Sheriff, Helen
    Morgan, Charity
    Najjar, Samer S.
    Chlebowski, Rowan
    Klein, Liviu
    Eaton, Charles B.
    Howard, Barbara V.
    Ahmed, Ali
    Mohammed, Selma
    CIRCULATION, 2019, 140
  • [39] Cardiovascular risk in postmenopausal women with and without breast cancer
    Conde, Delio M.
    Costa-Paiva, Lucia
    Martinez, Edson Z.
    Pinto-Neto, Aarao M.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2014, 183 : 10 - 11
  • [40] Metabolic syndrome and the risk of breast cancer in postmenopausal women
    Rosato, V.
    Bosetti, C.
    Talamini, R.
    Levi, F.
    Montella, M.
    Giacosa, A.
    Negri, E.
    La Vecchia, C.
    ANNALS OF ONCOLOGY, 2011, 22 (12) : 2687 - 2692